Application Of A Novel Temperature Shift Process For Particle Engineering

Source: Lonza

By John Baumann, head of R&D Advanced Engineering Technologies – Small Molecule, Lonza


Spray drying of amorphous dispersions improves solubility and bioavailability that enables supersaturation in the intestine, driving higher rates of absorption when compared to crystalline drug forms. Additionally, techniques have been developed to allow greater degrees of freedom when selecting process solvents for spray dried dispersion manufacture, including heated processing and volatile acidic/basic compounds to dissolve active pharmaceutical ingredients (APIs) in a wider range of less toxic or hazardous solvents.

Recent advances in spray drying have allowed for additional degrees of freedom in selecting solution compositions to avoid solvents that are either hard to remove from the spray dried powders, are not compendial, or are environmentally harmful and challenging to manage from a waste management perspective. Lonza, a global contract development and manufacturing organization (CDMO), possesses a wealth of expertise in particle engineering, and has pioneered a novel, temperature shift spray drying process that can be applied to APIs that are poorly soluble in organic spray solvents at room temperature. By immediately heating the solution prior to the nozzle for short times (<60 seconds), large solubility increases can be achieved while minimizing degradation of the API. This approach can enable molecules that may have been deemed unable to progress using standard approaches.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Pharmaceutical Online